% alzhub.org library filter
% Source: https://alzhub.org/research?author=Fortea+J&access=free
% 7 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{fortea2024-38710950,
  author  = {Fortea, J. and Pegueroles, J. and Alcolea, D. and Belbin, O. and Dols-Icardo, O. and Vaqué-Alcázar, L. and Videla, L. and Gispert, J. D. and others},
  title   = {{APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease}},
  journal = {Nature medicine},
  year    = {2024},
  doi     = {10.1038/s41591-024-02931-w},
  pmid    = {38710950},
  url     = {https://doi.org/10.1038/s41591-024-02931-w}
}

@article{rubenstein2024-39312235,
  author  = {Rubenstein, E. and Tewolde, S. and Michals, A. and Weuve, J. and Fortea, J. and Fox, M. P. and Pescador Jimenez, M. and Scott, A. and others},
  title   = {{Alzheimer Dementia Among Individuals With Down Syndrome}},
  journal = {JAMA network open},
  year    = {2024},
  doi     = {10.1001/jamanetworkopen.2024.35018},
  pmid    = {39312235},
  url     = {https://doi.org/10.1001/jamanetworkopen.2024.35018}
}

@article{suarezcalvet2016-26941262,
  author  = {Suárez-Calvet, M. and Kleinberger, G. and MÁ, Araque Caballero and Brendel, M. and Rominger, A. and Alcolea, D. and Fortea, J. and Lleó, A. and others},
  title   = {{sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers}},
  journal = {EMBO molecular medicine},
  year    = {2016},
  doi     = {10.15252/emmm.201506123},
  pmid    = {26941262},
  url     = {https://doi.org/10.15252/emmm.201506123}
}

@article{fortea2021-34687637,
  author  = {Fortea, J. and Zaman, S. H. and Hartley, S. and Rafii, M. S. and Head, E. and Carmona-Iragui, M.},
  title   = {{Alzheimer's disease associated with Down syndrome: a genetic form of dementia}},
  journal = {The Lancet. Neurology},
  year    = {2021},
  doi     = {10.1016/s1474-4422(21)00245-3},
  pmid    = {34687637},
  url     = {https://doi.org/10.1016/s1474-4422(21)00245-3}
}

@article{garciaayllon2017-28559572,
  author  = {García-Ayllón, M. S. and Lopez-Font, I. and Boix, C. P. and Fortea, J. and Sánchez-Valle, R. and Lleó, A. and Molinuevo, J. L. and Zetterberg, H. and others},
  title   = {{C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease}},
  journal = {Scientific reports},
  year    = {2017},
  doi     = {10.1038/s41598-017-02841-7},
  pmid    = {28559572},
  url     = {https://doi.org/10.1038/s41598-017-02841-7}
}

@article{rubenstein2025-41105592,
  author  = {Rubenstein, E. and Tewolde, S. and Michals, A. and Fortea, J. and Jimenez, M. P. and Skotko, B. G. and Tripodis, Y. and Weuve, J. and others},
  title   = {{Novel predictors of Alzheimer's disease in Down syndrome identified using machine learning}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2025},
  doi     = {10.1177/13872877251385423},
  pmid    = {41105592},
  url     = {https://doi.org/10.1177/13872877251385423}
}

@article{moreau2022-35740400,
  author  = {Moreau, M. and Carmona-Iragui, M. and Altuna, M. and Dalzon, L. and Barroeta, I. and Vilaire, M. and Durand, S. and Fortea, J. and others},
  title   = {{DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients}},
  journal = {Biomedicines},
  year    = {2022},
  doi     = {10.3390/biomedicines10061380},
  pmid    = {35740400},
  url     = {https://doi.org/10.3390/biomedicines10061380}
}